88 related articles for article (PubMed ID: 10484424)
1. NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation.
Hassid A; Yao J; Huang S
Am J Physiol; 1999 Sep; 277(3):H1014-26. PubMed ID: 10484424
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk.
Lin Y; Ceacareanu AC; Hassid A
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H710-21. PubMed ID: 12714323
[TBL] [Abstract][Full Text] [Related]
3. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism.
Sreejayan N; Lin Y; Hassid A
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1086-92. PubMed ID: 12117721
[TBL] [Abstract][Full Text] [Related]
4. Role of PTP-1B in aortic smooth muscle cell motility and tyrosine phosphorylation of focal adhesion proteins.
Hassid A; Huang S; Yao J
Am J Physiol; 1999 Jul; 277(1):H192-8. PubMed ID: 10409197
[TBL] [Abstract][Full Text] [Related]
5. Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility.
Brown C; Lin Y; Hassid A
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1598-605. PubMed ID: 11557549
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology.
Brown C; Pan X; Hassid A
Circ Res; 1999 Apr; 84(6):655-67. PubMed ID: 10189353
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-induced motility in aortic smooth muscle cells: role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho.
Chang Y; Ceacareanu B; Dixit M; Sreejayan N; Hassid A
Circ Res; 2002 Sep; 91(5):390-7. PubMed ID: 12215487
[TBL] [Abstract][Full Text] [Related]
8. Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells.
Palen DI; Belmadani S; Lucchesi PA; Matrougui K
Cardiovasc Res; 2005 Nov; 68(2):268-77. PubMed ID: 15967421
[TBL] [Abstract][Full Text] [Related]
9. Treatment with insulin uncovers the motogenic capacity of nitric oxide in aortic smooth muscle cells: dependence on Gab1 and Gab1-SHP2 association.
Dixit M; Zhuang D; Ceacareanu B; Hassid A
Circ Res; 2003 Nov; 93(10):e113-23. PubMed ID: 14551245
[TBL] [Abstract][Full Text] [Related]
10. NO decreases phosphorylation of focal adhesion proteins via reduction of Ca in rat aortic smooth muscle cells.
Kaur K; Yao J; Pan X; Matthews C; Hassid A
Am J Physiol; 1998 May; 274(5):H1613-9. PubMed ID: 9612371
[TBL] [Abstract][Full Text] [Related]
11. NO increases protein tyrosine phosphatase activity in smooth muscle cells: relationship to antimitogenesis.
Dhaunsi GS; Matthews C; Kaur K; Hassid A
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1342-9. PubMed ID: 9087610
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide attenuates IGF-I-induced aortic smooth muscle cell motility by decreasing Rac1 activity: essential role of PTP-PEST and p130cas.
Ceacareanu AC; Ceacareanu B; Zhuang D; Chang Y; Ray RM; Desai L; Chapman KE; Waters CM; Hassid A
Am J Physiol Cell Physiol; 2006 Apr; 290(4):C1263-70. PubMed ID: 16354758
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP.
Zhuang D; Ceacareanu AC; Lin Y; Ceacareanu B; Dixit M; Chapman KE; Waters CM; Rao GN; Hassid A
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2103-12. PubMed ID: 14751855
[TBL] [Abstract][Full Text] [Related]
14. Essential role of protein kinase G and decreased cytoplasmic Ca2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility.
Zhuang D; Ceacareanu AC; Ceacareanu B; Hassid A
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1859-66. PubMed ID: 15576431
[TBL] [Abstract][Full Text] [Related]
15. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition.
Callsen D; Pfeilschifter J; Brüne B
J Immunol; 1998 Nov; 161(9):4852-8. PubMed ID: 9794418
[TBL] [Abstract][Full Text] [Related]
16. Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components.
Yao J; Schoecklmann HO; Pröls F; Gauer S; Sterzel RB
Kidney Int; 1998 Mar; 53(3):598-608. PubMed ID: 9507204
[TBL] [Abstract][Full Text] [Related]
17. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells.
Redmond EM; Cahill PA; Hodges R; Zhang S; Sitzmann JV
J Cell Physiol; 1996 Mar; 166(3):469-79. PubMed ID: 8600150
[TBL] [Abstract][Full Text] [Related]
18. Interdependence of steroidogenesis and shape changes in Y1 adrenocortical cells: studies with inhibitors of phosphoprotein phosphatases.
Whitehouse BJ; Gyles SL; Squires PE; Sayed SB; Burns CJ; Persaud SJ; Jones PM
J Endocrinol; 2002 Mar; 172(3):583-93. PubMed ID: 11874707
[TBL] [Abstract][Full Text] [Related]
19. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
[TBL] [Abstract][Full Text] [Related]
20. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
Guvakova MA; Surmacz E
Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
